Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bone Substitute in the Multi Traumatized Nasal Septum Reconstruction

NCT: NCT01234415 · COMPLETED

NCT IDNCT01234415
StatusCOMPLETED
Start Date2011-09
Completion2014-11

Brief Summary

The aim of this project is to evaluate the safety and efficacy of the biomaterial made of HAP/TCP (BCP, Kasios®), in septoplasties of multi traumatized human nose. The use of this biomaterial will avoid the graft sampling and we expect it to be a good substitute to support the nasal pyramid while favouring the respiratory epithelium regeneration. Thus, that would confirm previous in vitro and in vivo studies.

Frequently Asked Questions

What is Bone Substitute in the Multi Traumatized Nasal Septum Reconstruction?

Bone Substitute in the Multi Traumatized Nasal Septum Reconstruction is a clinical trial registered under NCT01234415. Current status: COMPLETED.

What is the status of NCT01234415?

The current status of NCT01234415 (Bone Substitute in the Multi Traumatized Nasal Septum Reconstruction) is: COMPLETED.

When did Bone Substitute in the Multi Traumatized Nasal Septum Reconstruction start?

Bone Substitute in the Multi Traumatized Nasal Septum Reconstruction started on 2011-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.